The ESCMID Fungal Infection Study Group (EFISG) is dedicated to fostering a strong network and promoting knowledge sharing through engaging educational activities, insightful conferences, and impactful publications. It's goal is to boost global awareness and management of fungal diseases (FDs) among everyone, from healthcare professionals and researchers to the general public. FDs are a growing threat to public health, driven by a shifting epidemiology, increasing resistance, and limited available treatments. It's within this context that the EFISG steps up as a key global player. They have been at the forefront, advising the World Health Organization (WHO) on prioritising fungal pathogens, and supporting efforts to enhance diagnostics, develop better antifungal treatments, and strengthen resistance surveillance, all in collaboration with international mycology societies.
Together, EFISG is committed to:
Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion.
de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, Babady E, Bai F-Y, Balada-Llasat J-M, Borman A, Chowdhary A, Clark A, Colgrove RC, Cornely OA, Dingle TC, Dufresne PJ, Fuller J, Gangneux J-P, Gibas C, Glasgow H, Graser Y, Guillot J, Groll AH, Haase G, Hanson K, Harrington A, Hawksworth DL, Hayden RT, Hoenigl M, Hubka V, Johnson K, Kus JV, Li R, Meis JF, Lackner M, Lanternier F, Leal SM Jr, Lee F, Lockhart SR, Luethy P, Martin I, Kwon-Chung KJ, Meyer W, Nguyen MH, Ostrosky-Zeichner L, Palavecino E, Pancholi P, Pappas PG, Procop GW, Redhead SA, Rhoads DD, Riedel S, Stevens B, Sullivan KO, Vergidis P, Roilides E, Seyedmousavi A, Tao L, Vicente VA, Vitale RG, Wang Q-M, Wengenack NL, Westblade L, Wiederhold N, White L, Wojewoda CM, Zhang SX. Reply to Kidd et al., J Clin Microbiol. 2024 Apr 10;62(4):e0162523
Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.
Bassetti M, ... ; Study Group for Infections in Critically Ill Patients of the European Society of Clinical Microbiology and Infectious Diseases (ESGCIP), the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG), the European Society of Intensive Care Medicine (ESICM), the European Confederation of Medical Mycology (ECMM), the Mycoses Study Group Education and Research Consortium (MSGERC), the International Society of Antimicrobial Chemotherapy (ISAC), the International Society for Human and Animal Mycology (ISHAM), the Austrian Society for Medical Mycology (ÖGMM), the Italian Society of Anesthesia, Analgesia, Reanimation, and Intensive Care (SIAARTI), the Italian Society of Anti-Infective Therapy (SITA), and the FUNDICU Collaborators. Intensive Care Med. 2024 Apr;50(4):502-515.
Invasive fungal disease in the immunocompromised host: changing epidemiology, new antifungal therapies, and management challenges.
Giannella M, Lanternier F, Dellière S, Groll AH, Mueller NJ, Alastruey-Izquierdo A, Slavin MA; ECCMID study groups on Invasive Fungal Infection and Infection in Immunocompromised Hosts. Clin Microbiol Infect. 2024 Aug 12:S1198-743X(24)00386-0
European Study of Cerebral Aspergillosis treated with Isavuconazole (ESCAI): A study by the ESCMID Fungal Infection Study Group.
Serris A, Rautemaa-Richardson R, Laranjinha JD, Candoni A, Garcia-Vidal C, Alastruey-Izquierdo A, Hammarström H, Seidel D, Styczynski J, Sabino R, Lamoth F, Prattes J, Warris A, Porcher R, Lanternier F; ESCAI Study Group. Clin Infect Dis. 2024 Oct 15;79(4):936-943
A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI,ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC
de Hoog S, Walsh TJ, Ahmed SA, Alastruey-Izquierdo A, Alexander BD, Arendrup MC, Babady E, Bai F-Y,Balada-Llasat J-M, Borman A, Chowdhary A, Clark A, Colgrove RC, Cornely OA, Dingle TC, Dufresne PJ, Fuller J, Gangneux J-P, Gibas C, Glasgow H, Gräser Y,Guillot J, Groll AH, Haase G, Hanson K, Harrington A, Hawksworth DL, Hayden RT, Hoenigl M, Hubka V,Johnson K, Kus JV, Li R, Meis JF, Lackner M, Lanternier F, Leal SM Jr, Lee F, Lockhart SR, Luethy P, Martin I,Kwon- Chung KJ, Meyer W, Nguyen MH, Ostrosky-Zeichner L, Palavecino E, Pancholi P, Pappas PG, ProcopGW, Redhead SA, Rhoads DD, Riedel S, Stevens B, Sullivan KO, Vergidis P, Roilides E, Seyedmousavi A, Tao L,Vicente VA, Vitale RG, Wang Q-M, Wengenack NL, Westblade L, Wiederhold N, White L, Wojewoda CM, Zhang SX. Guidelines or Consensus Documents. J Clin Microbiol. 2023;61(11):e0087323.
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
Daniele Roberto Giacobbe, Silvia Dettori, Vincenzo Di Pilato, Erika Asperges, Lorenzo Ball, Enora Berti,Ola Blennow, Bianca Bruzzone, Laure Calvet, Federico Capra, Marzani, Antonio Casabella, Sofia Choudaly, Anais Dartevel, Gennaro De Pascale, Gabriele Di Meco,Melissa Fallon, Louis-Marie Galerneau, Miguel Gallego, Mauro Giacomini, Adolfo González Sáez, LuiseHänsel, Giancarlo Icardi, Koehler P, Katrien Lagrou, Tobias Lahmer, P. Lewis White, Laura Magnasco,Anna Marchese, Cristina Marelli, Mercedes Marín-Arriaza, Ignacio Martin-Loeches, Armand Mekontso-Dessap, Malgorzata Mikulska, Wauters J, Pelosi P, Timsit JF, Bassetti M; JIR-ICU investigators(collaborators); Critically Ill Patients Study Group of the European Society of Clinical Microbiology andInfectious Diseases (ESGCIP), and the Fungal Infection Study Group of the European Society of Clinical Microbiology and Infectious Diseases (EFISG).Crit Care. 2023;27(1):323.
Update on the diagnosis of Pneumocystis pneumonia – it is all much clearer now!
16 July 2025 at 15:00 CET
Battling Candida auris and other fungal threats: A new era of prevention and protection for vulnerable patients
11 June 2025 at 15:00 CET
Update of Invasive Fungal Diseases (IFDs) in immunocompromised children
6 March 2025 at 16:00-18:00 CET
Invasive mould wound infection - Lessons from regions under conflicts
18 February 2025 at 15:00-16:00 CET
Remaining questions answered by the speakers
Current concepts in immunotherapy for opportunistic mycoses in patients with hematologic cancer
13 January 2025 at 15:00 CET
The fungal exposome and health issues
Technical workshop
22-23 June 2023, Rennes, France
If you have questions or comments for our study group, we warmly invite you to contact us!
